Table 3.
Haplotypes of the tested genes concerning the analysed phenotypes in HD patients
| Gene | Polymorphisms | Haplotype | Freq. | Case, Control Frequencies | Chi Square | P Value | Pcorr Valuea | OR (95% CI), p valueb | OR (95% CI), p valuec |
|---|---|---|---|---|---|---|---|---|---|
| myocardial infarction = CASES, without myocardial infarction = CONTROLS | |||||||||
| LXRA | rs2279238_rs7120118 | GT | 0.693 | 0.646, 0.705 | 4.810 | 0.028 | 0.078 | reference | 0.761 (0.596–0.971), 0.028 |
| AC | 0.168 | 0.165, 0.169 | 0.036 | 0.849 | 0.993 | 1.068 (0.777–1.468), 0.685 | 0.973 (0.713–1.328), 0.863 | ||
| GC | 0.139 | 0.190, 0.126 | 9.791 | 0.002 | 0.005* | 1.645 (1.202–2.252), 0.002 | 1.624 (1.194–2.208), 0.002* | ||
| rs11039155_rs2279238_rs7120118 | GGT | 0.692 | 0.646, 0.704 | 4.565 | 0.033 | 0.098 | reference | 0.771 (0.602–0.989), 0.040 | |
| AAC | 0.160 | 0.157, 0.160 | 0.033 | 0.857 | 1.000 | 1.064 (0.769–1.472), 0.709 | 0.976 (0.710–1.342), 0.883 | ||
| GGC | 0.137 | 0.184, 0.124 | 8.828 | 0.003 | 0.005* | 1.598 (1.162–2.198), 0.004 | 1.580 (1.156–2.159), 0.004* | ||
| dyslipidaemia by K/DOQI criteria = CASES, without dyslipidaemia by K/DOQI criteria = CONTROLS | |||||||||
| ENHO | rs72735260_rs2281997 | GC | 0.582 | 0.549, 0.619 | 8.786 | 0.003 | 0.008* | reference | 0.756 (0.624–0.917), 0.004* |
| GT | 0.278 | 0.314, 0.238 | 12.299 | 5.0E-4 | 0.001* | 1.483 (1.191–1.846), 0.0004 | 1.471 (1.189–1.819), 0.0004* | ||
| TC | 0.133 | 0.128, 0.138 | 0.434 | 0.5101 | 0.773 | 1.045 (0.785–1.390), 0.7645 | 0.921 (0.698–1.215), 0.562 | ||
| atherogenic dyslipidaemia = CASES, without atherogenic dyslipidaemia = CONTROLS | |||||||||
| ENHO | rs72735260_rs2281997 | GC | 0.582 | 0.618, 0.544 | 9.824 | 0.002 | 0.004* | reference | 1.343 (1.109–1.627), 0.003* |
| GT | 0.278 | 0.244, 0.314 | 10.532 | 0.001 | 0.004* | 0.687 (0.553–0.854), 0.0007 | 0.704 (0.570–0.869), 0.001* | ||
| TC | 0.133 | 0.132, 0.133 | 0.002 | 0.968 | 1.000 | 0.880 (0.661–1.172), 0.3825 | 0.994 (0.753–1.312), 0.966 | ||
| LXRA | rs11039155_rs2279238 | GG | 0.827 | 0.803, 0.853 | 7.496 | 0.0062 | 0.009* | reference | 0.714 (0.550–0.927), 0.011* |
| AA | 0.161 | 0.182, 0.137 | 6.433 | 0.0112 | 0.028* | 1.401 (1.079–1.819), 0.0111 | 1.401 (1.079–1.819), 0.011* | ||
| rs2279238_rs7120118 | GT | 0.693 | 0.676, 0.711 | 2.423 | 0.1196 | 0.249 | reference | 0.846 (0.689–1.039), 0.110 | |
| AC | 0.168 | 0.190, 0.145 | 6.363 | 0.0117 | 0.029* | 1.386 (1.069–1.797), 0.0135 | 1.391 (1.077–1.796), 0.011* | ||
| GC | 0.139 | 0.134, 0.145 | 0.424 | 0.5151 | 0.795 | 0.978 (0.741–1.291), 0.8776 | 0.819 (0.699–1.207), 0.541 | ||
| rs11039155_rs2279238_rs7120118 | GGT | 0.692 | 0.676, 0.708 | 2.094 | 0.1479 | 0.416 | reference | 0.873 (0.709–1.074), 0.199 | |
| AAC | 0.160 | 0.180, 0.137 | 5.942 | 0.0148 | 0.023* | 1.369 (1.049–1.785), 0.0204 | 1.384 (1.065–1.798), 0.015* | ||
| GGC | 0.137 | 0.129, 0.145 | 0.917 | 0.3382 | 0.750 | 0.935 (0.706–1.236), 0.6351 | 0.882 (0.669–1.162), 0.370 | ||
Significant P-values are indicated using an asterisk
aThe p-value was calculated using the permutation test and 1000 permutations
bThe most common haplotype was used as the reference
cAll other haplotypes pooled together were used as the reference
Only ENHO and LXRA haplotypes yielded significant results after correction